Literature DB >> 675786

Consequences of helminth aggregation for the dynamics of schistosomiasis.

D J Bradley, R M May.   

Abstract

The distribution of schistosome worms among their human hosts is not random but aggregated. The consequences of introducing aggregation into models of schistosomiasis transmission, especially that of Macdonald, are explored. There are two possibilities for aggregation, with the sexes distributed either independently or together. Both have profound though differing effects on the breakpoint concept, which is largely destroyed when the sexes are aggregated together, and Macdonald's epidemiological conclusions are not robust to variations from the Poisson distribution. The conclusion from his model that if schistosome densities in man are reduced appropriately the infection will spontaneously proceed to extinction even in the presence of conditions suitable for transmission, is also not therefore robust.

Entities:  

Mesh:

Year:  1978        PMID: 675786     DOI: 10.1016/0035-9203(78)90205-5

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  11 in total

1.  The six diseases of WHO. Schistosomiasis: some advances.

Authors:  G Webbe
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-24

2.  Genetic Background Affects the Mucosal Secretory IgA Levels, Parasite Burden, Lung Inflammation, and Mouse Susceptibility to Ascaris suum Infection.

Authors:  Luciana Maria Oliveira; Denise Silva Nogueira; Ricardo Marcelo Geraldi; Fernando Sérgio Barbosa; Chiara Cássia Oliveira Amorim; Ana Clara Gazzinelli-Guimarães; Nathália Maria Resende; Natália Pinheiro-Rosa; Lucas Rocha Kraemer; Matheus Silvério Mattos; Lilian Lacerda Bueno; Ana Maria Caetano Faria; Remo Castro Russo; Soraya Gaze; Ricardo Toshio Fujiwara
Journal:  Infect Immun       Date:  2021-11-22       Impact factor: 3.609

3.  Familial aggregation of human susceptibility to co- and multiple helminth infections in a population from the Poyang Lake region, China.

Authors:  Magda K Ellis; Giovanna Raso; Yue-Sheng Li; Zhu Rong; Hong-Gen Chen; Donald P McManus
Journal:  Int J Parasitol       Date:  2007-02-27       Impact factor: 3.981

4.  The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages.

Authors:  Anneke S de Vos; Wilma A Stolk; Luc E Coffeng; Sake J de Vlas
Journal:  PLoS Negl Trop Dis       Date:  2021-05-12

5.  Mathematical modeling of solid cancer growth with angiogenesis.

Authors:  Hyun M Yang
Journal:  Theor Biol Med Model       Date:  2012-02-02       Impact factor: 2.432

6.  Assessing the effects of multiple infections and long latency in the dynamics of tuberculosis.

Authors:  Hyun M Yang; Silvia M Raimundo
Journal:  Theor Biol Med Model       Date:  2010-11-08       Impact factor: 2.432

7.  Schistosoma mansoni Infections in young children: when are schistosome antigens in urine, eggs in stool and antibodies to eggs first detectable?

Authors:  J Russell Stothard; Jose Carlos de Sousa-Figueiredo; Jose C Sousa-Figuereido; Martha Betson; Moses Adriko; Moses Arinaitwe; Candia Rowell; Fred Besiyge; Narcis B Kabatereine
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04

8.  Neglected diseases of neglected populations: thinking to reshape the determinants of health in Latin America and the Caribbean.

Authors:  John P Ehrenberg; Steven K Ault
Journal:  BMC Public Health       Date:  2005-11-11       Impact factor: 3.295

9.  Associations between maternal helminth and malaria infections in pregnancy and clinical malaria in the offspring: a birth cohort in entebbe, Uganda.

Authors:  Juliet Ndibazza; Emily L Webb; Swaib Lule; Harriet Mpairwe; Miriam Akello; Gloria Oduru; Moses Kizza; Helen Akurut; Lawrence Muhangi; Pascal Magnussen; Birgitte Vennervald; Alison Elliott
Journal:  J Infect Dis       Date:  2013-07-31       Impact factor: 5.226

10.  Population biology of Schistosoma mating, aggregation, and transmission breakpoints: more reliable model analysis for the end-game in communities at risk.

Authors:  David Gurarie; Charles H King
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.